
Nxera Pharma Co., Ltd. — Investor Relations & Filings
Nxera Pharma Co., Ltd. (formerly Sosei Group Corp.) is a technology-driven biopharmaceutical company focused on the discovery and early development of novel medicines. The company utilizes its proprietary StaR® technology and world-leading expertise in G protein-coupled receptor (GPCR) structure-based drug design (SBDD) to create therapeutics for diseases with high unmet medical needs. By integrating advanced science and technology, Nxera Pharma develops its internal pipeline and collaborates with partners to accelerate the creation of life-changing treatments for patients worldwide. Its mission is to invest in science and technology to accelerate the development of these medicines.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 訂正有価証券届出書(参照方式) | 2026-04-15 | Japanese | |
| 訂正有価証券届出書(参照方式) | 2026-04-15 | Japanese | |
| 臨時報告書 | 2026-04-15 | Japanese | |
| 臨時報告書 | 2026-04-15 | Japanese | |
| 訂正有価証券届出書(参照方式) | 2026-03-25 | Japanese | |
| 訂正有価証券届出書(参照方式) | 2026-03-25 | Japanese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 34566876 | 訂正有価証券届出書(参照方式) | 2026-04-15 | Japanese | ||
| 34566871 | 訂正有価証券届出書(参照方式) | 2026-04-15 | Japanese | ||
| 34566860 | 臨時報告書 | 2026-04-15 | Japanese | ||
| 34566851 | 臨時報告書 | 2026-04-15 | Japanese | ||
| 33038059 | 訂正有価証券届出書(参照方式) | 2026-03-25 | Japanese | ||
| 33038056 | 訂正有価証券届出書(参照方式) | 2026-03-25 | Japanese | ||
| 33037861 | 確認書 | 2026-03-25 | Japanese | ||
| 33037785 | 有価証券報告書-第36期(2025/01/01-2025/12/31) | 2026-03-25 | Japanese | ||
|
2025
7 filings
| |||||
| 9889892 | 訂正有価証券届出書(参照方式) | 2025-12-12 | Japanese | ||
| 9889883 | 訂正有価証券届出書(参照方式) | 2025-12-12 | Japanese | ||
| 9336417 | 訂正有価証券届出書(参照方式) | 2025-12-05 | Japanese | ||
| 9336410 | 訂正有価証券届出書(参照方式) | 2025-12-05 | Japanese | ||
| 7858932 | 訂正有価証券届出書(参照方式) | 2025-08-08 | Japanese | ||
| 7858930 | 訂正有価証券届出書(参照方式) | 2025-08-08 | Japanese | ||
| 7858896 | 確認書 | 2025-08-08 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Nxera Pharma Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/11386/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=11386 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=11386 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=11386 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 11386}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Nxera Pharma Co., Ltd. (id: 11386)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.